The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Research Communications Manager
Anna Carrera is the research communications manager for Indiana University's Precision Health Initiative, IU School of Medicine and the Indiana Clinical and Translational Sciences Institute. She joined the team in June 2019 after working as a TV news rep...
More than 140 golfers participated in the inaugural Tyler Trent Foundation “Tee Off for Tyler” Charity Golf Classic at the Bridgewater Club in Carmel. The event raised money for pediatric cancer research, including work being done by IU Precision Health Initiative pediatric sarcomas disease research team co-leaders, Jamie Renbarger, MD, and Karen Pollok, PhD.
The IU School of Medicine researcher who led the school’s effort to test a COVID-19 vaccine is now co-leading a nationwide clinical trial about cystic fibrosis. Cynthia Brown, MD, has several years of experience with clinical trials, including a decade seeing and treating patients with cystic fibrosis. This latest study is the first of its kind, using a smartphone app to track cystic fibrosis outcomes.
An IU School of Medicine researcher and his colleagues have determined that human gut bacteria composition correlates with the severity of malaria in children through the use of samples from clinical studies performed in Uganda and animal models. Nathan Schmidt, PhD, associate professor of pediatrics at IU School of Medicine, is the senior author of this study, published this month in Cell Reports.
James Wood, MD, a pediatrician and assistant professor of pediatric infectious diseases, explains what doctors know today about the risk children face of getting and spreading the coronavirus and when vaccines might be available.
It’s been about a year since COVID-19 patients first flooded intensive care units (ICU) around Indiana. IU School of Medicine Bicentennial Professor W. Graham Carlos, MD, who also serves as the Eskenazi Health Chief of Medicine, spends most of his time in Eskenazi Health’s ICU and has watched several surges during the last few months.
At Indiana University School of Medicine, the 2020 fiscal year set another record for NIH-funded research, with the school’s faculty attracting federal support for research about Alzheimer’s disease, genomic-guided therapies, cancer research and more.
Cynthia Brown, MD, who leads the AstraZeneca COVID-19 vaccine study at the IU School of Medicine, is being featured in a new short-form documentary by BBC News. The video also includes study participants Joe Morris and Mia McLendon.
A surgeon, IT worker and retired manufacturer are among the participants in the IU School of Medicine late stage clinical study of an investigational COVID-19 vaccine known as AZD1222. They spoke with members of the media during a virtual press conference, where lead researcher, Cynthia Brown, MD, also gave updates about progress made in the study so far.
Indiana University School of Medicine researchers have contributed to four studies published in one journal, all related to their research, designed to eliminate malaria in the Eastern Africa country of Kenya. These studies involved about 8,000 people over ten-years, looking at how insecticide-treated bed nets impact disease transmission, tracking disease hotspots, and analyzing antibody profiles against disease in participants over time.
Indiana University School of Medicine is pleased to welcome new faculty member, Weidong Xiao, PhD, a world-renowned authority in gene therapy. Xiao’s expertise includes the development of a molecular tool for the transfer of genes called adeno-associated viral (AAV) vectors.